The previous and our studies suggest that ATP6V1C2 displays distinct expression status, and prognostic role among different cancers and the molecular mechanisms of ATP6V1C2 related to COAD, RCC, and BC are different. This evidence concerns the gene ATP6V1C2 and renal cell carcinoma.